The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models-Reference-Cited by-同舟云学术

The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models

Published:2015-07-29 Issue:1 Volume:13 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Penny Melissa A,Galactionova Katya,Tarantino Michael,Tanner Marcel,Smith Thomas A

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1186/s12916-015-0408-2/fulltext.html

Reference33 articles.

1. The RTS,S Clinical Trials Partnership 2014. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a Phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014; 11:1001685.

2. Ballou WR. The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunology. 2009; 31:492–500.

3. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, et al.First results of Phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011; 365:1863–75.

4. Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, et al.A Phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012; 367:2284–295.

5. Leach A, Vekemans J, Lievens M, Ofori-Anyinam O, Cahill C, Owusu-Agyei S, et al.Design of a Phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J. 2011; 10:224.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria treatment for prevention: a modelling study of the impact of routine case management on malaria prevalence and burden;2024-06-26

2. An Estimate Of The Return On Investment Of A Malaria Vaccine In 20 Sub-Saharan African Countries, 2021–30;Health Affairs;2023-08-01

3. Does ignoring transmission dynamics lead to underestimation of the impact of interventions against mosquito-borne disease?;BMJ Global Health;2023-08

4. Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana;Health Policy and Planning;2022-09-09

5. A brief history of selected malaria vaccine and medical interventions pursued by the Swiss Tropical and Public Health Institute and partners, 1943-2021;Acta Tropica;2022-01